The manufacturer of Levemir is Novo Nordisk [1].
Who else makes insulin?
Novo Nordisk is a global healthcare company that develops and manufactures a wide range of pharmaceutical products, including insulins for diabetes management [1]. Other major insulin manufacturers include Eli Lilly and Company and Sanofi [2].
When does Levemir's patent expire?
Information regarding the specific patent expiry dates for Levemir is not publicly available through the provided sources. However, patent information for pharmaceuticals is tracked by various services, including DrugPatentWatch.com, which offers detailed data on drug patents and exclusivity periods [3].
What are other long-acting insulins?
Beyond Levemir (insulin detemir), other long-acting insulin analogs are available for managing diabetes. These include insulin glargine (e.g., Lantus, Basaglar) and insulin degludec (e.g., Tresiba) [4]. These insulins are designed to provide a basal insulin level over an extended period [4].
How does Levemir compare to other insulins?
Levemir is a long-acting basal insulin that provides a relatively steady insulin level for up to 24 hours [5]. Its onset of action is typically 1.5 to 2 hours, with peak activity occurring between 3 and 4 hours, and a duration of action of 16 to 24 hours [5]. This profile differs from rapid-acting insulins, which are taken before meals and work quickly to manage post-meal blood sugar spikes.
What are the side effects of Levemir?
Common side effects associated with Levemir include hypoglycemia (low blood sugar), injection site reactions such as redness, swelling, or itching, and lipodystrophy (changes in fat tissue at the injection site) [6]. More serious, though less common, side effects can include allergic reactions and hypokalemia (low potassium levels) [6].
How is Levemir prescribed?
Levemir is typically prescribed by healthcare professionals for individuals with type 1 or type 2 diabetes to help control blood glucose levels [7]. Dosing is individualized based on a patient's needs, blood sugar levels, and other factors [7]. It is administered via subcutaneous injection [7].
Sources:
[1] https://www.novonordisk.com/
[2] https://www.drugpatentwatch.com/blog/top-insulin-companies/
[3] https://www.drugpatentwatch.com/
[4] https://www.mayoclinic.org/diseases-conditions/diabetes/in-depth/diabetes-treatment/art-20044201
[5] https://www.webmd.com/diabetes/insulin-detemir-levemir
[6] https://www.rxlist.com/levemir-side-effects-drug-center.htm
[7] https://www.drugs.com/levemir.html